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ABSTRACT
Mammalian testicular spermatozoa are immotile, thus, to
reach the oocyte, they need to acquire swimming ability under
the control of different factors acting during the sperm transit
through the epididymis and the female genital tract. Although
bicarbonate is known to physiologically increase motility by
stimulating soluble adenylate cyclase (sAC) activity of mamma-
lian spermatozoa, no extensive studies in human sperm have
been performed yet to elucidate the additional molecular mech-
anisms involved. In this light, we investigated the effect of in
vitro addition of bicarbonate to human spermatozoa on the
main intracellular signaling pathways involved in regulation of
motility, namely, intracellular cAMP production and protein ty-
rosine phosphorylation. Bicarbonate effects were compared
with those of the phosphatidyl-inositol-3 kinase inhibitor,
LY294002, previously demonstrated to be a pharmacological
stimulus for sperm motility. Bicarbonate addition to spermato-
zoa results in a significant increase in sperm motility as well as
in several hyperactivation parameters. This stimulatory effect of
bicarbonate and LY294002 is mediated by an increase in cAMP
production and tyrosine phosphorylation of the A kinase an-
choring protein, AKAP3. The specificity of bicarbonate effects
was confirmed by inhibition with 4,49-di-isothiocyanostilbene-
2,29-disulfonic acid. We remark that, in human spermatozoa,
bicarbonate acts primarily through activation of sAC to stimu-
late tyrosine phosphorylation of AKAP3 and sperm motility be-
cause both effects are blunted by the sAC inhibitor 2OH-estra-
diol. In conclusion, our data provide the first evidence that bi-
carbonate stimulates human sperm motility and hyperactivation
through activation of sAC and tyrosine phosphorylation of
AKAP3, finally leading to an increased recruitment of PKA to
AKAP3.
cyclic adenosine monophosphate, kinases, signal transduction,
sperm motility and transport
INTRODUCTION
Mammalian spermatozoa released from the testis are im-
motile and unable to fertilize. To reach the oocyte and ac-
quire the competence to fertilize, they need to undergo a
sequential series of complex processes of activation con-
sisting of maturation and acquisition of motility in the ep-
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ididymis as well as capacitation and development of the
hyperactivated motility in the female reproductive tract. All
these processes are under the control of different factors
acting during the sperm transit through the epididymis and
the female uterus and oviduct. Among these factors, bicar-
bonate (HCO32) has been demonstrated to play a pivotal
role in regulating sperm capacitation and acrosome reaction
in mammalian spermatozoa [1–14]. Moreover, a recent
finding indicates the importance of HCO32 for a correct
spermatogenesis in germ-cell differentiation in the mouse
[15]. Although it is known that HCO32 increases motility
by stimulating adenylate cyclase activity and cAMP pro-
duction in mammalian spermatozoa, the majority of the
data have been obtained in the mouse and in the boar (for
review, see [16]) and only few studies have been performed
in human sperm [1, 4, 10, 17, 18]. Indeed, in the human,
a comprehensive study investigating the molecular mech-
anisms by which HCO32 stimulates sperm motility is lack-
ing.
Recently, we have demonstrated that pharmacological
inhibition of phosphatidyl inositol 3 kinase (PI3K) activity
by LY294002 stimulates human sperm motility by increas-
ing intracellular cAMP level and tyrosine phosphorylation
of AKAP3, an A kinase anchoring protein (AKAP) of the
fibrous sheath in sperm tails [19]. This effect finally leads
to the recruitment of PKA in this sperm compartment as-
sociated with an increase in sperm motility [20], pointing
out the relevance of such a mechanism in regulation of
human sperm motility.
In the present paper, for the first time, we perform a
complete analysis of the effect of HCO32 on sperm motility
and hyperactivation in swim-up-selected human spermato-
zoa in comparison with the effect of LY294002 by using
computer-assisted sperm analysis (CASA). Moreover, we
investigate the concomitant increase in cAMP levels, ty-
rosine phosphorylation of AKAP3 and AKAP3-PKA inter-
action, underlying HCO32 stimulation of sperm motility.
Similar to the action of LY294002, we report here that
HCO32 induces an increase in cAMP production and ty-
rosine phosphorylation of AKAP3 and other related pro-
teins, but unlike LY294002, without affecting PI3K activ-
ity.
Conflicting data exist about the nature of the mammalian
sperm adenylate cyclase. In fact, despite some studies de-
scribing the presence of the classical membrane adenylate
cyclase (mAC) [16, 21, 22], recent findings demonstrate the
prevalent expression in these cells of a distinct soluble ad-
enylate cyclase (sAC) [19, 23–25], which does not posses
a transmembrane domain, is insensitive to forskolin and G-
protein regulation and is selectively activated by HCO32 in
a pH-independent mechanism [18, 23–25]. The precise
compartmentalization of sAC in distinct subcellular micro-
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domains [26, 27] provides the mechanism for localized
cAMP rise to specifically activate PKA in different cellular
compartments. In fact, unlike mAC, cytosolic sAC associ-
ated with different cell organelles, could diffuse and gen-
erate cAMP at the site where its target enzyme PKA is
localized [28].
However, the coexistence of both mAC and sAC in sper-
matozoa could not be excluded and a functional interplay
between the two types of enzymes could be hypothesized
in regulating the timing of sperm acquisition of the maxi-
mal fertilization potential [29]. In this light, we decided to
further investigate the involvement of sAC in mediating the
effects of HCO32 in human sperm using the specific sAC
inhibitor 2OH-estradiol [30]. Our findings demonstrate that
sAC plays a major role in HCO32 stimulation of tyrosine
phosphorylation of AKAP3 in sperm tails, finally leading
to stimulation of sperm motility and hyperactivation.
MATERIALS AND METHODS
Chemicals
All reagents for human sperm preparation were from Irvine (Santa
Ana, CA). All reagents for sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) were from Amersham Pharmacia Biotech
Italia (Cologno Monzese, Italy). The conjugated secondary antibody,
2OH-estradiol, 17b-estradiol, and 4,49-di-isothiocyanostilbene-2,29-disul-
fonic acid (DIDS) as well as the other general reagents were purchased
from Sigma Chemical Co. (St. Louis, MO). Peroxidase-conjugated PY20
antibody, LY294002, and H89 were obtained from Calbiochem (La Jolla,
CA). [g-32P]ATP and the RIA kit for cAMP measurement were from NEN
Life Science (Boston, MA). Anti-AKAP3 FSP95 rat antibody was kindly
provided by Prof. John Herr (Charlottesville, VA) and LY303511 sup-
ported by Ely Lilly (Indianapolis, IN). The BM enhanced-chemilumines-
cence system was purchased from Roche Diagnostic (Milan, Italy). The
protein measurement kit was from Bio-Rad Laboratories, Inc. (Hercules,
CA).
Preparation of Spermatozoa
All the experiments were performed using spermatozoa from semen
samples obtained from men who met all the World Health Organization
(WHO) criteria for normozoospermia [31], after the approval of the Hos-
pital Committee for Investigations in Humans and after informed patient
consent. Samples with leukocytes and/or immature germ cell concentration
greater than 106/ml were not included in the study. Semen samples were
processed by swim-up technique as previously described [32]. Briefly, for
swim-up selection, 1-ml aliquots of semen were gently layered with 1 ml
of 1% human serum albumin (HSA)-Hepes-buffered human tubal fluid
(HTF) medium not containing HCO32. According to Holt and Harrison
[33], HCO32/CO2 was added in the form of suitable aliquots of a 750 mM
aqueous solution of NaHCO3 saturated with 100% CO2 (a ratio of HCO32:
CO2, yielding, after dilution, pH 7.4 at 378C); thus, such addition did not
disturb the pH of the medium. To prevent loss of CO2 during subsequent
incubation, the HCO32-containing samples were maintained under 5%
CO2 in air. After 1 h, 800 ml of the upper medium phase were collected
and checked for sperm count and motility. After washing, sperm samples
containing about 5 3 106 cells/ml were incubated in 1% HSA-Hepes-
buffered HTF medium not containing HCO32 for the indicated times with
the stimuli.
In some experiments, unselected ejaculated spermatozoa treated with
the different stimuli were subjected to motility evaluation according to the
WHO manual [31].
SDS-PAGE and Western Blot Analysis
After the different treatments, sperm samples were processed for SDS-
electrophoresis (SDS-PAGE) as previously described [20]. Briefly, sperm
samples were washed and resuspended in lysis buffer [20 mM Tris, pH
7.4, 150 mM NaCl, 0.25% NP-40, 1 mM Na3VO4, 1 mM phenylmethyl-
sulfonyl fluoride (PMSF)]. After protein measurement (Coomassie kit;
Bio-Rad Laboratories), the sperm extracts, containing approximately 30
mg of protein, were diluted in equal volume of 23 Laemmli reducing
sample buffer (62.5 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 2.5% py-
ronin, and 200 mM dithiothreitol), incubated at 958C for 5 min, and loaded
onto 8% or 10% polyacrylamide-bisacrylamide gels. After SDS-PAGE,
proteins were transferred to nitrocellulose. In some experiments, equiva-
lent protein loading was verified by staining parallel gels with Coomassie
R. After a 2-h incubation in 1% BM blocking (Roche) in TTBS solution
(Tris-buffered saline containing 0.1% Tween 20, pH 7.4), nitrocellulose
membranes were washed and then immunostained with peroxidase-con-
jugated PY20-HRP or anti-AKAP3 FSP95 antibody followed by peroxi-
dase-conjugated secondary antibody. The antibody-reacted proteins were
revealed by an enhanced-chemiluminescence system (BM; Roche). For
reprobing with different antibodies, nitrocellulose membranes were
washed for 30 min at 508C in stripping buffer (10 mM Tris, pH 6.8, 2%
SDS, 100 mM b-mercaptoethanol) and reprobed with the specific primary
antibodies.
Immunoprecipitation Analysis
Because AKAP3 is detergent resistant due to its strong association to
the fibrous sheath compartment, we used a SDS extraction method to lyse
spermatozoa before performing immunoprecipitation [20]. Briefly, 50 mil-
lion sperm were extracted in SDS-lysis buffer (20 mM Tris-HCl, pH 7.4,
0.2% SDS, 1 mM PMSF) for 30 min. After 5 min of boiling at 958C,
samples were kept for 10 min on ice and centrifuged at 127 000 rpm for
5 min at room temperature. Extracted supernatants were then subjected to
AKAP3 immunoprecipitation by first incubating for 1 h with 30 ml of
protein G-Sepharose for preclearing. Precleared lysates were then incu-
bated for 1 h using 3 mg of anti-AKAP3 antibody followed by overnight
incubation at 48C with 50 ml of protein G-Sepharose. The immunobeads,
obtained by centrifugation at 6000 rpm at 48C for 5 min, were washed
three times in lysis buffer and then resuspended in 10 ml of 23 reducing
sample buffer and subjected to SDS-PAGE followed by Western blot anal-
ysis.
PI3 Kinase Assay
PI3K activity was evaluated in an in vitro assay as previously described
[20]. Sperm samples treated or not for 15 min with 15 mM HCO32, 10
mM LY294002, or 10 mM LY303511 were extracted in lysis buffer A (20
mM Tris, pH 7.4, 137 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1% NP-
40, 1 mM Na3VO4, 1 mM PMSF). After protein measurement, aliquots
of sperm extracts containing equivalent amounts of proteins (300 mg) were
incubated for 1 h with 50 ml of protein G-Sepharose for preclearing. Pre-
cleared lysates were then incubated for 1 h using 3 mg of rabbit anti-p85
PI3K (06-195; Upstate Biotechnology, Lake Placid, NY) on ice followed
by overnight incubation at 48C with 50 ml of protein A-Sepharose. Se-
pharose beads were washed twice in lysis buffer and twice with a 10 mM
Tris-HCl (pH 7.4) containing 0.1 mM EGTA and 5 mM LiCl. Beads were
then suspended in kinase buffer (10 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA) containing 20 mg of L-a-phosphatidylinositol (Sigma Chemical
Co.), 25 mM MgCl2 and 10 mCi of [g32P]ATP and incubated for 20 min
at room temperature. Reaction was stopped by addition of 60 ml of 6 M
HCl and then 160 ml of chloroform:methanol (1:1) were added. Lipids
were then resolved by thin-layer chromatography plates (TLC silica gel
60) (Merck Laborchimica, Florence, Italy) in chloroform, methanol, water,
and ammonium hydroxide (60:47:11.3:2). Dried TLC sheets were devel-
oped by autoradiography. Band intensity quantification was performed us-
ing a Kodak image-analysis system. Aliquots (1:4) of the p85 immuno-
beads were subjected to Western blot analysis with the same antibody to
ensure that protein G pulled down the same amount of enzyme in both
samples (not shown).
Intracellular cAMP Levels
Sperm samples (5 3 106 cells) treated with 15 mM HCO32 for 1–15
min, were washed twice in PBS and overnight extracted in absolute eth-
anol at 2208C. Intracellular cAMP levels were evaluated by a RIA kit
(NEN Life Science, Boston, MA) in supernatants after centrifugation
(1000 g, 10 min), lyophilization, and reconstitution in 0.05 M sodium
acetate buffer, pH 6.2 [20]. Experiments were carried out in duplicate and
results expressed as percentage of stimulation over the control, taken as
100%.
Evaluation of Sperm Motility and Hyperactivation
Motility and hyperactivation parameters such as sort fraction (SF), av-
erage path velocity (VAP), curvilinear velocity (VCL), straight-line veloc-
ity (VSL), beat-cross frequency (BCF), linearity (LIN 5 VSL/VCL) and
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FIG. 1. HCO32 and LY294002 stimulate hyperactivation parameters VAP, VCL, VSL, BCF, LIN, and STR in swim-up-selected human spermatozoa.
Swim-up-selected sperm samples were incubated for the indicated times in the presence of increasing concentrations of HCO32 (1.5, 15, and 75 mM;
n 5 10) or LY294002 (10 mM, n 5 13) and average path velocity (VAP, A), curvilinear velocity (VCL, B), straight-line velocity (VSL, C), beat-cross
frequency (BCF, D), linearity (LIN, E), and straightness (STR, F) were evaluated by CASA. Data represent mean 6 SEM over the respective controls (0)
taken as 100%. Mean raw values are indicated for all the controls (VAP, VCL, VSL: mm/sec; BCF: Hz; LIN and STR: %). Dunnet test: *, P , 0.05; **,
P , 0.01; §, P , 0.005; #, P , 0.001 versus the respective controls (0).
straightness (STR 5 VSL/VAP) were evaluated by CASA (Hamilton
Thorn Research, Beverly, MA). The settings used during CASA proce-
dures were analysis duration of 1 sec (30 frames); minimum contrast, 80;
minimum size, 3; low size and high size gates, 0.7 and 2.6; low intensity
and high intensity gates, 0.34 and 1.40 [20]. A minimum of 100 cells and
four fields were analyzed for each aliquot. All analyses were performed
at 378C. Motility was expressed as forward and rapid motility (type a 1
b and type a motility, respectively, according to the WHO manual [31]).
Evaluation of Sperm Viability
Sperm viability was evaluated under phase-contrast light microscope
by the eosin technique or the hyposmotic swelling test, according to the
WHO manual [31].
Statistical Analysis
Data are expressed as mean 6 SEM for n experiments as indicated in
figure legends. In graphs showing data obtained by CASA, mean 6 SEM
were calculated by mediating data from the indicated number of experi-
ments, where every measurement was obtained by analyzing a minimum
of 100 cells and four fields for each sample, as indicated in the Evaluation
of Sperm Motility and Hyperactivation section.
Statistical analysis was performed with a Dunnet test when comparing
more than two classes of samples or with a Student t-test for paired or
unpaired data, when comparing two classes.
RESULTS
HCO32 Stimulates Motility and Hyperactivation
Parameters in Human Spermatozoa
Addition of sodium HCO32 to swim-up-selected sper-
matozoa results in a significant stimulation of rapid and
forward sperm motility, as evaluated by CASA (not
shown). The effect of HCO32 on sperm motility is similar
to that exerted by the PI3K inhibitor LY294002 (10 mM;
not shown), which has been previously demonstrated to be
an in vitro pharmacological stimulus of sperm motility [20,
32, 34]. To investigate whether the increase in the percent-
age of forward and rapid motility of spermatozoa induced
by HCO32 is associated with a change in sperm hyperac-
tivation, we measured the effect of the anion on those pa-
rameters associated with sperm hyperactivation using
CASA. Again, the effect of HCO32 was compared with that
of LY294002, previously shown to induce a significant in-
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FIG. 2. HCO32 but not forskolin increases intracellular cAMP levels in
swim-up-selected human spermatozoa. After different times of incubation
with HCO32 (15 mM) or with forskolin (50 mM, 10 min), swim-up-se-
lected sperm samples were washed and extracted in ethanol. Intracellular
cAMP concentrations were evaluated by a RIA kit. Mean raw values are
indicated for the control (time 0). Data represent means 6 SEM over the
control (time 0) taken as 100% from the indicated number of experiments.
Dunnet test: *, P , 0.05 versus 0.
FIG. 3. HCO32 stimulates tyrosine phosphorylation of sperm proteins in
a dose-dependent manner. Western blot analysis of sperm lysates from
swim-up-selected spermatozoa stimulated for 30 min with increasing con-
centrations of HCO32 (1.5, 15, and 75 mM). Tyrosine phosphorylated pro-
teins were revealed with PY20-HRP antibody (A) and after stripping with
anti-AKAP3 antibody (B). Molecular weight markers (Mr 3 1023) are in-
dicated to the left of the blots. Results are representative of three similar
experiments.
FIG. 4. HCO32 stimulates tyrosine phosphorylation of AKAP3. After a
15-min treatment, sperm samples were extracted in SDS-buffer and im-
munoprecipitated using anti-AKAP3 antibody (AKAP3) or with nonrelated
IgG. Western blot analysis of the immunoprecipitated beads using anti-
phosphotyrosine antibody (A, IB: PY20-HRP) or after stripping and re-
probing with anti-AKAP3 antibody (B, IB: AKAP3), is shown. Molecular
weight markers (Mr 3 1023) are indicated to the right of the blots. Results
are representative of three similar experiments.
crease in VAP, VSL, and VCL in swim-up-selected sper-
matozoa [20, 32, 34]. HCO32 (Fig. 1, A–F) induces a sig-
nificant dose-dependent increase in VAP, VCL, VSL, BCF,
LIN, and STR at all time points in swim-up-selected sper-
matozoa, similar to that exerted by LY294002 (10 mM).
Moreover, the ability of HCO32 to stimulate sperm hyper-
activation was further confirmed by the dose-response in-
crease in the sort fraction (SF), indicating the percentage
of hyperactivated spermatozoa in the sample (C: 9.2% 6
1.2%; 15 mM HCO32: 22.4% 6 2.9%; 75 mM HCO32:
33.3% 6 3.0%; n 5 30; Dunnet test: P , 0.001 versus
control for both concentrations). All the other hyperacti-
vation parameters seem to be only slightly affected at the
different time points and concentrations tested (not shown).
HCO32 Stimulates cAMP Production and Tyrosine
Phosphorylation of Sperm AKAP3: Involvement
of a Soluble Adenylate Cyclase
To investigate the molecular mechanisms underlying the
stimulatory effect of HCO32 on sperm motility, we mea-
sured the intracellular levels of cAMP in swim-up-selected
spermatozoa treated for different times with 15 mM
HCO32. As shown in Figure 2, HCO32 stimulates a rapid
and sustained increase in intracellular cAMP levels. In con-
trast, forskolin, a well-known pharmacological stimulus of
classic membrane adenylate cyclase, is ineffective, sug-
gesting the involvement of the soluble form of this enzyme,
which has been previously described to be present and ac-
tive in spermatozoa [18, 23, 25].
Because we have previously demonstrated that
LY294002 stimulates sperm motility by inducing a con-
comitant increase in cAMP production and tyrosine phos-
phorylation of AKAP3, a scaffolding protein mainly asso-
ciated with the fibrous sheath in sperm tail [20, 35–37], we
next studied the ability of HCO32 to influence the tyrosine
phosphorylation pattern of sperm proteins and, in particular,
of AKAP3.
Western blot analysis of sperm lysates using PY20HRP
antibody shows that sperm treatment with increasing doses
of HCO32 for 15 min induces a dose-dependent increase in
tyrosine phosphorylation of at least three major sperm pro-
teins of about 82, 86, and 110 kDa (Fig. 3A). Stripping and
reprobing the same membrane with anti-AKAP3 FSP95 an-
tibody reveals that the 110-kDa band comigrates with
AKAP3 (Fig. 3B). The identity of this 110-kDa band,
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FIG. 5. Tyrosine phosphorylation of sperm proteins is stimulated by
HCO32 in a time-dependent manner. Western blot analysis of sperm ly-
sates from swim-up-selected spermatozoa stimulated for different times
(0, 3, 10, 30 min) with HCO32 (HCO32 15 and 75 mM) using the PY20-
HRP antibody (A) or, after stripping and reprobing with anti-AKAP3 an-
tibody (B), is shown. Molecular weight markers (Mr 3 1023) are indicated
to the left of the blots. Results are representative of three similar experi-
ments.
FIG. 6. HCO32 increases the interaction of PKA with AKAP3 in human
spermatozoa. Swim-up-selected spermatozoa treated or not for 15 min
with 75 mM HCO32 were extracted in an immunoprecipitation buffer
containing 0.1% SDS and immunoprecipitated with anti-AKAP3 antibody.
Western blot analysis of the immunobeads using anti-PKA catalytic sub-
unit (A) or anti-AKAP3 (B) antibodies is shown. A total sperm lysate and
immunoprecipitated beads using nonrelated IgG were run as positive and
negative controls, respectively. Molecular weight markers (Mr 3 1023) are
indicated to the left of the blot. Results are representative of two similar
experiments.
TABLE 1. Dibutyryl cAMP reverts 2OH-estradiol inhibition of sperm motility. Swim-up-selected spermatozoa incubated for 15 min in the presence or
absence of 2OH-estradiol (2OH-E2, 20 mM) were added with 1mM dbcAMP, and motility parameters were evaluated by CASA. Data represent means
6 SEM obtained in five different experiments.
Control 2OH-E2 (20 mM) dbcAMP (1 mM) dbcAMP 1 2OH-E2
Motile (%)
Rapid (%)
Progressive (%)
Path velocity VAP (mm/sec)
43.5 6 3.12
17.5 6 3.12
15.2 6 3.17
59.8 6 2.62
21.5 6 6.35*
5.0 6 1.48*
2.5 6 0.64*
43.8 6 3.33*
64.5 6 5.85†
36.4 6 7.81†
32.7 6 5.79†
84.5 6 2.06†
71.5 6 5.56*
35.8 6 9.27*
32.7 6 5.79*
71.3 6 4.37*
* P , 0.05, Dunnett test, versus control.
† P , 0.001, Dunnett test, versus control.
which is tyrosine phosphorylated in response to HCO32, is
confirmed by immunoprecipitation experiments from
HCO32-treated sperm samples using the anti-AKAP3 anti-
body (Fig. 4). Western blot analysis using PY20HRP anti-
body as probe shows a marked increase in tyrosine phos-
phorylation of AKAP3 in HCO32-treated samples com-
pared with the control (Fig. 4A). Stripping and reprobing
the same membrane with anti-AKAP3 antibody shows that
this antibody pulls down the same amount of proteins in
the different samples (Fig. 4B). Moreover, it suggests that
the two additional proteins of 82 and 86 kDa, which are
tyrosine phosphorylated in response to HCO32 (Fig. 4A),
might be related to the AKAP family because they are im-
munoprecipitated and revealed by anti-AKAP3 antibody
(Fig. 4B). The same two additional bands are also revealed
in Western blot analysis of total lysates at higher film ex-
posure (not shown). The increase in tyrosine phosphoryla-
tion of AKAP3 and of the other two sperm proteins is al-
ready present after 3 min of stimulation with 15 and 75
mM HCO32 and is long lasting (Fig. 5), as it occurs for the
cAMP production induced by HCO32 (Fig. 2).
Because tyrosine phosphorylation of AKAP3 by
LY294002 treatment of human spermatozoa has been dem-
onstrated to result in an increased interaction of PKA with
this scaffolding protein [20], we investigated if this is the
case also for tyrosine phosphorylation of AKAP3 induced
by HCO32. Coimmunoprecipitation experiments in which
sperm protein extracts immunoprecipitated for AKAP3
were revealed in Western blot analysis with an antibody
against the PKA catalytic subunit to detect the amount of
this protein bound through its regulatory subunit to
AKAP3, show that 75 mM HCO32 increases the amount of
PKA catalytic subunit coimmunoprecipitated with AKAP3
compared with the control (Fig. 6A). Figure 6B shows the
stripping and reprobing of the same membrane as in Figure
6A with anti-AKAP3.
To demonstrate that the effects on sperm motility and
protein tyrosine phosphorylation are due to the entry of
HCO32 in the cells, we evaluated the effect of inhibition of
the HCO32 transport through plasma membrane using
DIDS [6,9]. As shown in Figure 7, addition of DIDs (18
and 54 mM) to swim-up-selected spermatozoa significantly
reduces the stimulatory effect of two different concentra-
tions of HCO32 (15 mM and 75 mM) on sperm rapid (Fig.
7A) and forward (not shown) motility, hyperactivation pa-
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FIG. 7. Inhibition of HCO32 transport by 4,49-di-isothiocyanostilbene-
2,29-disulfonic acid (DIDS) reverses the stimulatory effects of HCO32 on
both sperm motility and tyrosine phosphorylation of AKAP3. Swim-up-
selected spermatozoa were incubated for 15 min in the presence of in-
creasing concentrations of HCO32 (15 and 75 mM) with or without the
HCO32 transport inhibitor DIDS (18 and 54 mM), and both sperm motility
(A) and tyrosine phosphorylation of AKAP3 (B) were evaluated. Rapid
sperm motility (A) was evaluated by CASA and is expressed as percentage
of the control, taken as 100%. Mean raw value is indicated (%) for the
control. Data represent means 6 SEM obtained from five separate exper-
iments. Dunnet test: *, P , 0.05 versus controls (DIDS 0). B) Tyrosine
phosphorylation of sperm proteins was evaluated by Western blot analysis
using antiphosphotyrosine PY20HRP antibody (B, upper panel). After the
stripping procedure, AKAP3 was revealed by anti-AKAP3 antibody (B,
lower panel). Molecular weight markers (Mr 3 1023) are indicated to the
left of the blots. Results are representative of three similar experiments.
rameters (not shown), and tyrosine phosphorylation of
AKAP3 (Fig. 7B). Because washing away added DIDS res-
cues sperm motility (not shown), the inhibitory effect ex-
erted by this molecule seems to be due to a block of bi-
carbonate transporters rather than to an unspecific covalent
binding to sperm plasma membrane [38].
An increase in intracellular cAMP as the one stimulated
by HCO32 (Fig. 2) is followed by PKA activation, which
has been suggested to be involved in tyrosine phosphory-
lation of proteins and stimulation of sperm motility [7–9,
39, 40]. Thus, we investigated the relationship between
PKA activation and tyrosine phosphorylation of proteins in
mediating sperm motility by evaluating the effect of the
pharmacological inhibitor of PKA activity, H89, together
with the one of the tyrosine kinases, erbstatin A, on sperm
motility and tyrosine phosphorylation of proteins. As
shown in Figure 8, both H89 (50 mM) and erbstatin (12.5
mg/ml) significantly inhibit sperm rapid (A) and forward
(not shown) motility as well as VAP (B), VCL (C) and
VSL (D) in basal conditions and in the presence of HCO32.
However, while erbstatin only heavily affected tyrosine
phosphorylation of AKAP3, H89 slightly inhibited phos-
phorylation only at the highest dose of HCO32 (Fig. 9A).
However, this slight inhibition is neither statistically sig-
nificant nor comparable with the significant decrease in
sperm motility and hyperactivated parameters observed
when H89 is added in the presence of the 75 mM HCO32(Fig. 9C). These data strongly indicate that tyrosine phos-
phorylation of AKAP3 is not downstream to PKA activa-
tion by HCO32, although both processes finally converge
on stimulation of sperm motility.
The involvement of sAC in mediating HCO32 stimula-
tory effects is further confirmed by the ability of the selec-
tive inhibitor of sAC, 2OH-estradiol (2OH-E2, 20 mM)
[30], to significantly blunt the effect of two doses of HCO32(15 and 75 mM) on rapid motility (Fig. 10A), hyperacti-
vation parameters (Fig. 10, B–D) including sort fraction
(Fig. 10E), as well as on tyrosine phosphorylation of
AKAP3 (Fig. 10, F and G). 2OH-E2 exerts its inhibitory
effects also in basal conditions, in particular, on tyrosine
phosphorylation of AKAP3 (Fig. 10F), suggesting that sAC
is involved in the stimulatory effects of HCO32. 17b-estra-
diol (20 mM) used as negative control was ineffective both
on sperm motility and hyperactivation parameters (not
shown) as well as on tyrosine phosphorylation of proteins
(Fig. 10F). As shown in Figure 10, A–E, 2OH-E2 is able
to decrease motility parameters of swim-up-selected sper-
matozoa also in the absence of HCO32. This inhibitory ef-
fect is rescued by the subsequent addition of the cAMP-
stable analogue dibutyryl cAMP (dbcAMP; Table 1), fur-
ther confirming that this inhibitor actually blocks cAMP
production by sAC. In addition, the inhibitor reduces sperm
motility and hyperactivation parameters (VAP, VCL, VSL,
and BCF) also when added to ejaculated unselected sper-
matozoa, whereas 17b-estradiol (20 mM) is ineffective (Ta-
ble 2). 2OH-E2 toxicity was excluded by checking sperm
viability at different times of incubation (not shown). Over-
all, these findings indicate that sAC is constitutively active
in human spermatozoa and that such activity supports
sperm motility.
All the data presented suggest that HCO32 and
LY294002 increase sperm motility by converging on the
same signaling pathway involving stimulation of cAMP
production by sAC and tyrosine phosphorylation of
AKAP3 in sperm tails. Indeed, when added together, the
two compounds show no synergic effect on stimulation of
sperm motility and hyperactivation, again suggesting that
they both act on the same molecular mechanisms (not
shown).
Because LY294002 effects on motility are associated
with the inhibition of sperm PI3K [20], we also evaluated
PI3K activity in the presence of HCO32. As shown in Fig-
ure 11A, 15 min of incubation with 15 and 75 mM HCO32
does not affect PI3K activity (upper panel), whereas in the
same experiment, it stimulates sperm rapid and forward
motility as well as hyperactivation parameters (VAP, VCL,
VSL, lower panel) in a dose-dependent manner. For com-
parison, Figure 11B reports the inhibitory effects of sperm
pretreatment (15 min) with 10 mM LY294002 but not with
its inactive analogue, LY303511 [20, 41].
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FIG. 8. Both inhibition of PKA by H89
and of tyrosine kinases by erbstatin blocks
HCO32-induced increase in sperm motility.
Swim-up-selected spermatozoa were incu-
bated for 15 min in the presence of in-
creasing concentrations of HCO32 (15 and
75 mM) with or without H89 (50 mM) or
erbstatin (12.5 mg/ml). Rapid sperm motili-
ty (A), VAP (B), VCL (C), and VSL (D) were
evaluated by CASA. Data represent mean
6 SEM over the respective controls (0)
taken as 100% from eight different experi-
ments. Mean raw values are indicated for
all the controls (rapid motility: %; VAP,
VCL, VSL: mm/sec). Dunnet test: #, P ,
0.05; 15 and 75 mM HCO32 versus con-
trols without treatments. Student t-test: sta-
tistical significance between the two clas-
ses of treated and untreated samples is in-
dicated in the figure; *, P , 0.05, erbstatin
versus control without treatments.
TABLE 2. Inhibition of sAC by 2OH-estradiol affects sperm motility of unselected ejaculated human spermatozoa. Unslected ejaculated spermatozoa
were incubated for 15 min in the presence or absence of 2OH-estradiol (2OH-E2, 20 mM) or 17b-estradiol (17bE2, 20 mM) and motility parameters
were evaluated by CASA. Data represent means 6 SEM increase over the respective controls, taken as 100% in 12 different experiments. Mean raw
data are indicated in parentheses for the controls.
Control 2OH-E2 (20 mM) 17bE2 (20 mM)
Motile
Rapid
100.0 6 18.1
(43.8%)
100.0 6 19.1
(21.0%)
56.6 6 15.6*
49.3 6 14.6*
93.6 6 23.3
83.0 6 23.0
Path velocity, VAP
Track speed, VCL
100.0 6 4.0
(61.1 mm/sec)
100.0 6 4.2
(76.0 mm/sec)
71.6 6 14.1*
72.8 6 14.4*
97.5 6 5.5
98.3 6 6.1
Progressive velocity VSL
Beat frequency, BCF
100.0 6 4.1
(52.5 mm/sec)
100.0 6 17.3
(8.0 Hz)
49.6 6 9.7†
69.3 6 17.7
97.0 6 5.4
105.3 6 23.7
* P , 0.05, Dunnett test, versus control.
† P , 0.001, Dunnett test, versus control.
DISCUSSION
Several studies report the stimulatory effect exerted in
vitro by HCO32 on different mammalian sperm functions
such as capacitation, acrosome reaction, and motility. The
importance of this factor in regulating sperm physiological
activation also in vivo is suggested by exposure of sper-
matozoa to increasing concentrations of HCO32 during theirjourney from the testis to the site of fertilization. Indeed,
spermatozoa pass through an increasing gradient of HCO32
from the proximal (2 mM) to the distal epididymal fluid
(5–7 mM) and the seminal secretion (10–15 mM), finally
culminating in the uterus and oviductal fluid (35–90 mM)
[42–44], with an additional increase during ovulation [45].
A recent report demonstrates that coculture of sperm with
endometrial cells not expressing the cystic fibrosis trans-
membrane conductance regulator (CFTR), a cotransporter
of HCO32 and chloride, results in lower sperm capacitation
and fertilizing ability [44]. Moreover, an increased expres-
sion of CFTR in the apical region of epithelial cells has
been reported in the cauda compared with the initial seg-
ment and head of the epididymis [46], further suggesting
an increased secretion of HCO32 in the lumen of the distal
regions. The increased level of HCO32 in seminal plasma
compared with epididymal fluids should allow motility to
develop in the distal male genital tract. Okamura et al. [44]
showed a positive correlation between lower levels of
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FIG. 9. Inhibition of tyrosine kinases but not of PKA blocks the HCO32-
induced increase in sperm AKAP3 tyrosine phosphorylation. After evalu-
ation of sperm motility, at 15-min stimulation with HCO32 (15 and 75
mM) with or without H89 (50 mM) or erbstatin (E, 12.5 mg/ml), the same
sperm samples used in Figure 9 were processed for measurement of pro-
tein tyrosine phosphorylation. Western blot analysis of aliquots of sperm
lysates using antiphosphotyrosine PY20HRP antibody (A) and, after the
stripping procedure, with anti-AKAP3 antibody (B) is shown. Molecular
weight markers (Mr 3 1023) are indicated to the left of the blots. C) den-
sitometric evaluation of tyrosine phosphorylation of AKAP3 is calculated
in percentage of band intensity over the control, taken as 100%. Repre-
sentative of three similar experiments. Dunnet test: #, P , 0.001 versus
control. Student t-test: *, P , 0.001 versus 15 mM HCO32.
HCO32 in the semen of infertile men and poor sperm mo-
tility. Yet, in the male reproductive fluids, HCO32 levels
are kept low to prevent spermatozoa from undergoing pre-
mature activation and developing hyperactivated motility,
processes that are stimulated by the 3–4 higher HCO32 con-
centrations present in the female reproductive tract [47]. In
agreement with data previously obtained in porcine and
mouse spermatozoa [2, 33], we demonstrate here that phys-
iological concentrations of HCO32, similar to those found
in the female genital fluids and in the media used for in
vitro fertilization techniques, significantly stimulate human
sperm motility. The effect of HCO32 is similar to that ex-
erted by LY294002, a pharmacological inhibitor of PI3K,
previously demonstrated to stimulate human sperm motility
[20, 32, 34].
We also applied CASA to study modifications of the
different sperm motion parameters defining hyperactivation
under the effect of HCO32. This peculiar pattern of motility,
associated with capacitation and characterized by a more
vigorous and less symmetric beat of the sperm flagellum
[48, 49], is essential for penetration of the cumulus oo-
phorus and the zona pellucida surrounding the oocyte.
HCO32 significantly stimulates hyperactivation in swim-up-
selected spermatozoa, enhancing not only VAP, VCL, VSL,
LIN, and STR, but also BCF and SF, which are the main
features characterizing hyperactivated motility [48, 49].
Similar to our data, a rapid stimulation of flagellar beat
frequency (occurring in seconds) exerted by HCO32 has
been recently described in mouse spermatozoa by using
stop-motion imaging and flagellar-waveform analysis [13].
The molecular mechanisms by which HCO32 stimulates
sperm motility and capacitation have not yet been fully
elucidated, in particular, in human spermatozoa. It has been
demonstrated that this ion is able to directly stimulate sAC,
with this effect being independent of an increase in intra-
cellular pH [1, 23, 50]. We show here that HCO32 rapidly
stimulates both an increase in cAMP and tyrosine phos-
phorylation of sperm AKAP3. Both effects are sustained,
lasting over 15 min for cAMP, even in the absence of phos-
phodiesterase inhibitors and over 1 h for protein phosphor-
ylation. That the effect of 15 mM HCO32 on AKAP3 phos-
phorylation is mediated by a specific activation of sAC is
demonstrated by the ability of 2OH-estradiol to reverse it,
whereas 17b-estradiol, used as negative control, is ineffec-
tive. Moreover, addition of dbcAMP to sperm sample is
able to rescue 2OH-estradiol inhibition, indicating that this
inhibitor actually blocks sAC-mediated cAMP production
in human spermatozoa rather than interferes with Na1/K1
ATPase or mitochondrial ATPase [51]. The importance of
sAC in regulating sperm motility has been recently stressed
by targeted disruption of the sAC gene in the mouse, which
dramatically impairs sperm forward motility and in vitro
fertilizing ability, without affecting spermatogenesis [52].
Interestingly, motility can be restored in sAC KO mice by
cAMP administration, suggesting the importance of cAMP
in switching on the biochemical pathway leading to sperm
motility rather then a direct influence of sAC in the struc-
tural function of the flagellum [52]. Although, in our hands,
forskolin was not able to stimulate a significant increase in
cAMP production in human spermatozoa, we cannot ex-
clude the presence of mAC isoforms that could cooperate
with sAC in regulating sperm functions.
A strict relationship between the AC/cAMP/PKA path-
way and tyrosine phosphorylation of sperm proteins in reg-
ulating sperm motility and capacitation has been estab-
lished in different species [12]. In particular, tyrosine phos-
phorylation of flagellar proteins has been associated with
increased sperm motility and hyperactivation [20, 53].
Here, we show that AKAP3 is the main phosphorylated
protein in response to HCO32. The importance of AKAP
scaffolding proteins in regulating sperm motility has been
remarked very recently, as KO mice for the Akap4 gene,
closely related to Akap3, show defects in sperm flagellum
and motility [54]. Tyrosine phosphorylation of AKAP3 dur-
ing capacitation [35–37] and in response to LY294002
treatment [20] has been demonstrated to play a key role in
PKA recruitment and activation at the level of sperm tails
[20, 55]. In fact, tyrosine phosphorylation of AKAP3 is
associated with an increased binding of the protein to PKA,
resulting in the recruitment and activation of the enzyme in
this specific cell compartment, finally leading to an increase
in sperm motility [20]. We demonstrate here that HCO32
stimulates an increased interaction of PKA catalytic subunit
with AKAP3. Thus, because both HCO32 and LY294002
stimulate cAMP production, tyrosine phosphorylation of
30 LUCONI ET AL.
FIG. 10. The sAC inhibitor 2OH-estradiol
blocks the HCO32-induced increase in
motility and tyrosine phosphorylation of
proteins in swim-up-selected spermatozoa.
Swim-up-selected spermatozoa were incu-
bated for 15 min with increasing concen-
trations of HCO32 (15 and 75 mM) after
10 min treatment with 2OH-estradiol
(2OH-E2 20 mM) or 17b-estradiol (17bE2
20 mM). Rapid motility (A) and hyperacti-
vation parameters VAP (B), VCL (C), VSL
(D), and sort fraction (SF; E) were evaluat-
ed by CASA. Data represent means 6 SEM
over the controls (untreated samples), tak-
en as 100% obtained from 13 separate ex-
periments. Mean raw values are indicated
for all the controls (rapid motility: %; VAP,
VCL, VSL: mm/sec; SF: %). Dunnet test: #,
P , 0.001, 15 and 75 mM HCO32 versus
0. Student t-test: statistical significance be-
tween 2OH-E2-treated and untreated sam-
ples is indicated in the different panels.
After motion measurements, Western blot
analysis of aliquots of treated samples us-
ing antiphosphotyrosine PY20HRP anti-
body (F) and, after stripping and reprobing,
anti-AKAP3 antibody (G), confirms the
identity of the protein band at 110 kDa
with AKAP3. Molecular weight markers
(Mr 3 1023) are indicated to the right of
the blots. Results are representative of two
similar experiments.
AKAP3 and an increased interaction of PKA with AKAP3,
resulting in stimulation of sperm motility, it can be reason-
ably concluded that the two compounds act on the same
signaling pathway, as is also suggested by the absence of
any synergic effect on sperm motility (data not shown).
However, HCO32 stimulation of sAC and AKAP3 phos-
phorylation appears to be independent of PI3K activity in-
hibition (Fig. 11A).
Evidence has been reported suggesting that PKA acts
upstream of protein tyrosine phosphorylation in mediating
sperm capacitation and motility [7–10, 12, 17]. However,
conflicting results on H89 ability to affect sperm motility
and protein tyrosine phosphorylation in different species
are present in the literature [13, 33, 39, 40, 56–58]. In par-
ticular, in human sperm, Aitken et al. [39] reported an in-
hibition of protein tyrosine phosphorylation but not of mo-
tility by H89, whereas Bajpai and Doncel [58] and our
group [20 and the present paper] demonstrated an inhibition
of motility without significant effects on protein tyrosine
phosphorylation. Thus, an alternative hypothesis can been
proposed according to which, at least in human sperm, PKA
activation is not essential for tyrosine phosphorylation, both
processes being essential for motility. Indeed, we report that
the time course of cAMP production and protein tyrosine
phosphorylation in response to HCO32 (present paper) and
to LY294002 [20] is very rapid, starting at 1–3 min after
addition of the stimulus and thus suggesting that tyrosine
phosphorylation and PKA activation may occur simulta-
neously. The apparent contrast with what has been reported
is by other authors [9, 10, 14, 17, 59] can be explained by
either species differences or simply because phosphoryla-
tion was measured only after longer incubation intervals
(15–240 min) with respect to measurement of cAMP pro-
duction peak (1–3 min, [16, 60]). Moreover, we demon-
strate that H89 inhibits sperm motility only and not tyrosine
phosphorylation of AKAP3, whereas both processes are
blocked by inhibition of tyrosine kinases by erbstatin A,
suggesting that tyrosine phosphorylation of AKAP3 is es-
sential for activation of PKA in stimulating sperm motility.
However, it cannot be excluded that PKA activation could
contribute to potentiating a second wave of tyrosine phos-
phorylation associated with a general phosphorylation of
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FIG. 11. HCO32 does not affect PI3K activity. Swim-up-selected sper-
matozoa were treated for 15 min with HCO32 (15 and 75 mM) or with
10 mM LY294002 or LY303511. PI3K activity was evaluated in sperm
samples by an in vitro assay after immunoprecipitation with anti-p85 PI3K
regulatory antibody. The spots correspond to the PI3K catalytic product
[32P] phosphatidyl inositol-phosphate (PIP). A) PI3K activity was evaluated
in the HCO32-treated sperm samples (upper panel) together with sperm
motility (rapid and forward) and hyperactivation parameters (VAP, VCL,
VSL) as measured by CASA (lower table). Data represent means 6 SEM
obtained from 12 separate experiments. Dunnet test: *, P , 0.05; **, P
, 0.001; §, P , 0.005; #, P , 0.001 versus control. B) PI3K activity was
evaluated in the same spermatozoa treated with the active (LY294002) or
the inactive (LY303511) inhibitor of the enzyme for comparison.
PKA substrates, as suggested by Harrison [61]. In conclu-
sion, our study sheds new light on the molecular mecha-
nisms underlying the physiological stimulation of sperm
motility by HCO32 in human spermatozoa, demonstrating
the direct involvement of sAC and tyrosine phosphorylation
of AKAP3 acting upstream of PKA activation.
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